Managing Patients Treated with Bevacizumab Combination Therapy

Publisher： Karger

E-ISSN： 1423-0232|69|3|25-33

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.3, 2005-11, pp. : 25-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study

By  

Oncology, Vol. 82, Iss. 4, 2012-04 ,pp. : 218-227

Karger

Access to resources Recommend Favorite

An Open-Label Safety Study of First-Line Bevacizumab in Combination with Standard Chemotherapy in Chinese Patients with Metastatic Colorectal Cancer Treated in an Expanded Access Program in Taiwan

By  

Oncology, Vol. 84, Iss. 5, 2013-03 ,pp. : 299-304

Karger

Access to resources Recommend Favorite

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 676-681

Karger

Access to resources Recommend Favorite

Lupus Panniculitis Treated by a Combination Therapy of Hydroxychloroquine and Quinacrine

By  

THE JOURNAL OF DERMATOLOGY, Vol. 24, Iss. 9, 1997-09 ,pp. : 569-572

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open‐label, single‐arm, noncomparative trial

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 61-68

John Wiley & Sons Inc

Access to resources Recommend Favorite